Dishman Carbogen Amcis Ltd has developed and manufactured several niche and high added-value Generic APIs in specific therapeutic fields. Our product portfolio focuses on complex intermediates and APIs and covers specific therapeutic areas such as anesthetics, contrast media agents for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes.

Our goal is to be a reliable partner with a strong know-how in API production and committed to manufacturing the highest quality APIs for our clients, with:

• local client support
• facilities approved by globally recognized health agencies
• expertise in process optimization and commercial scale-up into cGMP manufacturing
• worldwide distribution in both regulated and semi-regulated markets
• RSMs captive manufactured to ensure regulatory compliance
• open and flexible approach to customers' needs
• extensive regulatory approval expertise: in-house preparation and submissions of DMFs in EU /USA and several countries worldwide
• expertise in particle size distribution & micronization capabilities enable us to meet customer's specification of particle size

Our highly skilled and motivated Research and Development team have a passion for optimizing chemistry and analytical processes to ensure that we can introduce products rapidly, compliantly, and offer the appropriate value to our clients and ultimately to patients.

We operate continuously on a 3 shift / 6 days per week basis within R&D operations with strict IP protection policies with an almost unrivaled range of chemistry capabilities & expertise, allowing us to offer non-infringing processes.

Our services and products are focused on providing the best possible value on a long-term basis to our clients.

Disinfectant APIs

Download

Our facilities are regularly inspected by multiple regulatory authorities, ensuring all sites operate to the highest international standard of quality, safety, and environmental control.

We have a dedicated project management team, recognizing the diversity of our clients by deploying a flexible approach to all projects, with local representation and support in all territories. This allows intimate cooperation with all customers during all stages of project reviews, along with bespoke and customized solutions suited for each case and scenario.

Dishman Carbogen Amcis Ltd invest in strong, tenured leadership at both corporate and local levels, operating under strictly robust and secure protection policies that assure protection of our clients' Intellectual Property (IP) at every stage of the management process.

Our Supply Chain Management team sources raw materials, facilitating secure transfers, managing storage, and a rapid supply; ensuring timely delivery to all of our customers while maintaining full compliance with all safety and regulatory standards.

The Dishman Carbogen Amcis Ltd global supply chain presence, backed by nearly 40 years of experience, helps us secure materials within prescribed times and at the best value.

With local teams in India, the United Kindom, Switzerland, China, and Holland, we can ensure understanding and compliance with the often complex regional requirements & local storage - giving flexibility in deliveries and the reduction of cross border customs costs while ensuring our clients' materials arrive where and when they are needed.

Welcome to the Dishman Carbogen Amcis Ltd website. Our organization has embarked upon a new and exciting era; therefore, our online presence has undergone a complete refresh and total restructuring.

Please feel free to contact us with any queries or browse our newly refurbished corporate portal.

The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.

COVID-19 UPDATE

We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to market while improving the lives of their patients across the world.

Our objective is to help our customers create a better world as the partner of choice to develop and manufacture complex and challenging substances, highly potent active ingredients, and breaking new ground with innovative vitamin, healthcare, and industrial products.

Dishman Carbogen Amcis Ltd focusses on the reduction of operational risk in chemical development and commercial manufacturing by:

•• Minimising the time associated with drug development
•• Decreasing the risks associated with drug development
•• Providing long-term and value-added contract manufacturing solutions